Precision Biosciences (DTIL) Equity Income (2021 - 2025)
Historic Equity Income for Precision Biosciences (DTIL) over the last 5 years, with Q3 2025 value amounting to -$591000.0.
- Precision Biosciences' Equity Income rose 3245.71% to -$591000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 million, marking a year-over-year decrease of 27782.3%. This contributed to the annual value of -$1.1 million for FY2024, which is 7801.66% up from last year.
- According to the latest figures from Q3 2025, Precision Biosciences' Equity Income is -$591000.0, which was up 3245.71% from -$2.5 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Equity Income ranged from a high of $2.6 million in Q4 2022 and a low of -$2.5 million during Q2 2025
- In the last 5 years, Precision Biosciences' Equity Income had a median value of -$950000.0 in 2024 and averaged -$597117.6.
- Examining YoY changes over the last 5 years, Precision Biosciences' Equity Income showed a top increase of 299333.33% in 2022 and a maximum decrease of 75036.5% in 2022.
- Over the past 5 years, Precision Biosciences' Equity Income (Quarter) stood at -$90000.0 in 2021, then soared by 2993.33% to $2.6 million in 2022, then tumbled by 133.45% to -$871000.0 in 2023, then tumbled by 129.74% to -$2.0 million in 2024, then soared by 70.46% to -$591000.0 in 2025.
- Its last three reported values are -$591000.0 in Q3 2025, -$2.5 million for Q2 2025, and $1.3 million during Q1 2025.